Literature DB >> 6147455

Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy.

S Atkinson, M Holcombe, P Kendall-Taylor.   

Abstract

An IgG which binds specifically to retro-orbital antigen has been detected in patients with Graves' ophthalmopathy. By means of an assay which detects ophthalmopathic immunoglobulin (OIg) in patients' serum with an antigen prepared from porcine retro-orbital muscle, levels of OIg above the normal reference range were found in 21 of 33 (64%) patients with active untreated ophthalmopathy, in 3 of 12 (25%) with active disease already receiving steroid treatment, and in 3 of 18 (16%) with longstanding inactive eye disease. OIg was found in only 1 of 22 thyroid patients without eye disease. There was no correlation of OIg with thyrotropin-binding-inhibiting immunoglobulin nor with thyroid microsomal antibody, and there was no clear association with thyroglobulin antibody. Ophthalmopathy seems to be distinct from Graves' hyperthyroidism and the autoimmune response is directed to retro-orbital antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6147455     DOI: 10.1016/s0140-6736(84)90543-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report.

Authors:  F Ferracci; F Conte; B Marini; G Fassetta
Journal:  Ital J Neurol Sci       Date:  1997-08

3.  Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.

Authors:  J R Wall; H Triller; A Boucher; N F Bernard; M Salvi; M Ludgate
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

4.  Extraocular muscle changes in experimental orbital venous stasis: some similarities to Graves' orbitopathy.

Authors:  E Saber; J McDonnell; K M Zimmermann; J E Yugar; S E Feldon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

5.  T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.

Authors:  A P Weetman; P Fells; B Shine
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

6.  The pathogenesis and treatment of Graves' ophthalmopathy.

Authors:  I R Jones
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

7.  Endocrine regulation of the immune system.

Authors:  W Kiess; B H Belohradsky
Journal:  Klin Wochenschr       Date:  1986-01-02

8.  Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.

Authors:  W M Wiersinga; T Smit; R van der Gaag; L Koornneef
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

9.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

10.  A study of the binding of Graves' immunoglobulins to orbital antigens.

Authors:  K Banovac; S Levis; S F Byrne
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.